# Allelica

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/allelica

- Industry: Biotechnology
- Headquarters: US
- Website: www.allelica.com/
- Total disclosed funding: $1.8M
- Latest round: Seed (Mar 11, 2021)
- Investors on record: 3

## About

Allelica, Inc., based in New York, specializes in advanced genetic testing solutions, focusing on Polygenic Risk Score technology to facilitate personalized healthcare and improved risk assessments for various diseases.Founded in 2017, Allelica, Inc. provides innovative genetic testing solutions. The company was co-founded by Giordano Bottà and Paolo Di Domenico, with Giordano Bottà serving as CEO. Allelica raised USD 1.75 mn in a SEED funding round on March 11, 2021, led by Valor Ventures, along with Medical Genetics Center and Pi Campus. This round marked the sole deal for the company, raising a total of USD 1.75 mn to date.Allelica specializes in advanced genetic testing solutions, particularly Polygenic Risk Score (PRS) technology. Their primary product, the Allelica Precision Server (APS), offers on-premises analysis and clinical reporting of polygenic risk scores, pharmacogenomics, and carrier screening. The platform integrates comprehensive genetic insights into clinical practice, helping healthcare providers conduct personalized risk assessments across various disease categories, particularly cardiovascular diseases. The services are aimed at laboratories and healthcare providers, enhancing patient care and preventive healthcare strategies in North America and Europe.Allelica generates revenue primarily through subscriptions to its technology platform and partnerships with healthcare institutions and laboratories. Clients access Allelica’s offerings through a subscription model, allowing healthcare providers to incorporate genetic testing into their practices. The company engages in B2B transactions, supplying technology directly to medical laboratories and healthcare facilities, which rely on its tools for polygenic risk assessment. Specific pricing details are proprietary, reflecting the value of key products like the Allelica Precision Server.In March 2021, Allelica, Inc. secured USD 1.75 mn in Seed funding, which will be utilized to expand healthcare information technology and informatics in their largest market, North America. The company aims to develop new products and services that enhance its offerings in genetic testing and intends to broaden its market reach within the healthcare sector. Specific details on upcoming launches and geographic expansion plans have yet to be disclosed.

## Funding rounds

- Seed, Mar 11, 2021, $1.8M — Medical Genetics Center, Valor Ventures, Pi Campus

## Investors

- Medical Genetics Center — Seed
- Valor Ventures (https://capitalatlas.ai/funds/valor-ventures) — Seed
- Pi Campus (https://capitalatlas.ai/funds/pi-campus) — Seed